Since systemic inflammation represents a risk for developing neurodegeneration particularly for AD (for review see: Heneka et al, 2015), we analyzed the effects of a peripheral immune challenge on pathological hallmarks of AD using APP/PS1 mice. This evidence concerns the gene APP and Alzheimer disease.